Tumor‑associated macrophages in lung cancer: Friendly or evil? (Review)
Open accessAbstract
Typically, tumor‑associated macrophages (TAMs), an abundant population of leukocytes in lung cancer, are affected by tumor microenvironment (TME) and shift towards either a pro‑tumor (M2‑like) or an anti‑tumor phenotype (M1‑like). M2‑polarized macrophages, are one of the primary tumor‑infiltrating immune cells and were reported to be associated with the promotion of cancer cell growth, invasion, metastasis, and angiogenesis. TAMs are considered a potential target for adjuvant anticancer therapies, and recent therapeutic approaches targeting the M2 polarization of TAMs have shown encouraging results. The present review discusses recent developments in the role of TAMs in cancer, in particular TAMs functions, clinical implication and prospective therapeutic strategies in lung cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of the CCL2/CCR2 axis mediates crosstalk between TAMs and tumor cells and is associated with angiogenesis, metastases, immunosuppression, and cancer progression.
“The activation of the CCL2/CCR2 axis, which mediates the crosstalk between tumor-associated macrophages (TAMs) and tumor cells, is associated with angiogenesis, metastases, immunosuppression, and cancer progression [27,28].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [28]
The TAM-targeted therapeutics section (page unavailable) says CCL2–CCR2 may recruit macrophages and that blocking it may reduce TAM infiltration and reverse immunosuppression. The Functional aspects section links TAMs generally to angiogenesis, metastasis and cancer progression, but does not attribute those outcomes—or TAM–tumor-cell crosstalk specifically—to the CCL2/CCR2 axis. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · see citing works
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · see citing works
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840 · see citing works
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247 · see citing works
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · see citing works
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715 · see citing works
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474 · see citing works
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148 · see citing works
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D. H., Collins, L. I., Piwnica-Worms, D. R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943 · see citing works
Peranzoni, E., Lemoine, J., Vimeux, L., Feuillet, V., Barrin, S., Kantari-Mimoun, C., Bercovici, N., Guérin, M., Biton, J., Ouakrim, H., et al. (2018) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1720948115 · Cited by 817 · see citing works
Schoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., & Kerjaschki, D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64255-1 · Cited by 794 · see citing works
Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310514 · Cited by 739 · see citing works
Biswas, S. K. (2005) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 693 · see citing works
Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
Cao, M., Yan, H., Han, X., Weng, L., Qin, W. D., Sun, X., Lu, W., Wei, Q., Ye, J., Cai, X., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0817-4 · Cited by 557 · see citing works
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Hughes, R., Qian, B., Rowan, C., Muthana, M., Keklikoglou, I., Olson, O. C., Tazzyman, S. J., Danson, S. J., Addison, C., Clemons, M. J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3587 · Cited by 516 · see citing works
Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Talks, K., Pezzella, F., Gatter, K. C., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2018 · Cited by 478 · see citing works
Yeung, O. W. H., Lo, C. M., Ling, C.-C., Qi, X., Geng, W., Li, C. X., Ng, K. T., Forbes, S. J., Guan, X., Poon, R. T. P., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.029 · Cited by 453 · see citing works
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 439 · see citing works
Laoui, D., Overmeire, E. V., Conza, G. D., Aldeni, C., Keirsse, J., Morias, Y., Movahedi, K., Houbracken, I., Schouppe, E., Elkrim, Y., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1196 · Cited by 410 · see citing works
Welsh, T. J., Green, R. H., Richardson, D. L., Waller, D. A., O'Byrne, K. J., & Bradding, P. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4910 · Cited by 369 · see citing works
Li, W., Zhang, X., Wu, F., Zhou, Y., Bao, Z., Li, H., Zheng, P., & Zhao, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2131-y · Cited by 361 · see citing works
Tumor-Associated Macrophages in Breast Cancer
Leek, R., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 353 · see citing works
Dijkgraaf, E. M., Heusinkveld, M., Tummers, B., Vogelpoel, L. T. C., Goedemans, R., Jha, V., Nortier, J. W. R., Welters, M. J. P., Kroep, J. R., & van der Burg, S. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3542 · Cited by 346 · see citing works
Tumor promoting role of anti-tumor macrophages in tumor microenvironment
Goswami, K. K., Ghosh, T., Ghosh, S., Sarkar, M., Bose, A., & Baral, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.04.005 · Cited by 334 · see citing works
Chen, J. J. W., Yao, P., Yuan, A., Hong, T.-M., Shun, C., Kuo, M., Lee, Y.-C., & Yang, P. (2003) · PubMed · Cited by 309 · see citing works
Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00065708 · Cited by 296 · see citing works
Watkins, S. K., Egilmez, N. K., Suttles, J., & Stout, R. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1357 · Cited by 273 · see citing works
Huang, R., Wang, S., Wang, N., Zheng, Y., Zhou, J., Yang, B., Wang, X., Zhang, J., Guo, L., Wang, S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2435-y · Cited by 263 · see citing works
Helm, O., Held‐Feindt, J., Grage‐Griebenow, E., Reiling, N., Ungefroren, H., Vogel, I., Krüger, U., Becker, T., Ebsen, M., Röcken, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28736 · Cited by 262 · see citing works
Fu, X.-L., Duan, W., Su, C.-Y., Mao, F.-Y., Lv, Y.-P., Teng, Y.-S., Yu, P.-W., Zhuang, Y., & Zhao, Y.-L. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2052-5 · Cited by 242 · see citing works
Size dependent macrophage responses and toxicological effects of Ag nanoparticles
Park, J., Lim, D.-H., Lim, H.-J., Kwon, T., Choi, J., Jeong, S., Choi, I., & Cheon, J. (2011) · Chemical Communications · doi:10.1039/c1cc10357a · Cited by 239 · see citing works
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D., & Aharinejad, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3523 · Cited by 231 · see citing works
Wang, Q., Ni, H., Lan, L., Wei, X., Xiang, R., & Wang, Y. (2010) · Cell Research · doi:10.1038/cr.2010.52 · Cited by 219 · see citing works
Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
Jung, K. Y., Cho, S. W., Kim, Y. A., Kim, D., Oh, B., Park, D. J., & Park, Y. J. (2015) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2015.06.01 · Cited by 206 · see citing works
Klimp, A. H., Hollema, H., Kempinga, C., van der Zee, A. G. J., de Vries, E. G. E., & Daemen, T. (2001) · PubMed · Cited by 199 · see citing works
Sarode, P., Zheng, X., Giotopoulou, G. A., Weigert, A., Kuenne, C. T., Günther, S., Friedrich, A., Gattenlöhner, S., Stiewe, T., Brüne, B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6105 · Cited by 192 · see citing works
Zhang, B., Yao, G., Zhang, Y., Gao, J., Yang, B., 饶智国, & 高建飞 (2011) · Clinics · doi:10.1590/s1807-59322011001100006 · Cited by 188 · see citing works
Wang, R., Zhang, J., Chen, S., Lu, M., Luo, X., Yao, S., Liu, S., Qin, Y., & Chen, H. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.04.009 · Cited by 188 · see citing works
Sharma, S., Chintala, N. K., Vadrevu, S. K., Patel, J., Karbowniczek, M., & Markiewski, M. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403215 · Cited by 184 · see citing works
Wang, D., Yang, L., Yue, D., Cao, L., Li, L., Wang, D., Ping, Y., Shen, Z., Zheng, Y., Wang, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.040 · Cited by 183 · see citing works
Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis
Qiao, J., Liu, Z., Dong, C., Luan, Y., Zhang, A., Moore, C., Fu, K., Peng, J., Wang, Y., Ren, Z., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.005 · Cited by 179 · see citing works
STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis
Gong, M., Zhuo, X., & Ai-qun, M. (2017) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.904014 · Cited by 177 · see citing works
Zhang, W., Xu, W., & Xiong, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904016 · Cited by 177 · see citing works
Li, Y., Dong, Y., Li, Y., Wang, D., Liu, S., Wang, D., Gao, Q., Ji, S., Chen, X., Lei, Q., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32151 · Cited by 175 · see citing works
Allavena, P., Sica, A., Vecchi, A., Locati, M., Sozzani, S., & Mantovani, A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17714.x · Cited by 172 · see citing works
Salvagno, C., Ciampricotti, M., Tuit, S., Hau, C., van Weverwijk, A., Coffelt, S. B., Kersten, K., Vrijland, K., Kos, K., Ulas, T., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0298-1 · Cited by 168 · see citing works
TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice
Maeda, H., Kuwahara, H., Ichimura, Y., Ohtsuki, M., Kurakata, S., & Shiraishi, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4926 · Cited by 167 · see citing works
M2 tumor‑associated macrophages promote tumor progression in non‑small‑cell lung cancer
Sumitomo, R., Hirai, T., Fujita, M., Murakami, H., Otake, Y., & Huang, C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8068 · Cited by 161 · see citing works
Gridelli, C., Perrone, F., & Monfardini, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10050-8 · Cited by 161 · see citing works
Dai, F., Liu, L.-X., Che, G., Yu, N., Pu, Q., Zhang, S., Ma, J., Ma, L., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-220 · Cited by 151 · see citing works
Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages
Koscsó, B., Csóka, B., Kókai, E., Németh, Z. H., Pacher, P., Virág, L., Leibovich, S. J., & Haskó, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113043 · Cited by 147 · see citing works
CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis
Olmes, G., Büttner-Herold, M. J., Ferrazzi, F., Distel, L. V., Amann, K., & Daniel, C. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0989-y · Cited by 144 · see citing works
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
Cao, L., Che, X., Qiu, X.-S., Li, Z., Yang, B., Wang, S., Hou, K., Fan, Y., Qu, X., & Liu, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s199832 · Cited by 144 · see citing works
Sugimura, K., Miyata, H., Tanaka, K., Takahashi, T., Kurokawa, Y., Yamasaki, M., Nakajima, K., Takiguchi, S., Mori, M., & Doki, Y. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23881 · Cited by 140 · see citing works
Wang, R., Lu, M., Chen, H., Chen, S., Luo, X., Qin, Y., & Zhang, J. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-62 · Cited by 139 · see citing works
Che, D., Zhang, S., Jing, Z., Shang, L., Jin, S., Liu, F., Shen, J., Li, Y., Hu, J., Meng, Q., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.06.018 · Cited by 135 · see citing works
Zhang, J., Cao, J., Ma, S., Dong, R., Meng, W., Ying, M., Weng, Q., Chen, Z., Ma, J., Fang, Q., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1856 · Cited by 131 · see citing works
Macrophages limit chemotherapy
Palma, M. D., & Lewis, C. E. (2011) · Nature · doi:10.1038/472303a · Cited by 128 · see citing works
Li, Y., Cao, F., Li, M., Li, P., Yu, Y., Xiang, L., Xu, T., Lei, J., Tai, Y., Zhu, J., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0938-5 · Cited by 125 · see citing works
Essential role of interferon regulatory factor 4 (IRF4) in immune cell development
Nam, S., & Lim, J. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0854-1 · Cited by 124 · see citing works
DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
Liu, Q., Li, A., Yu, S., Qin, S., Han, N., Pestell, R. G., Han, X., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0597-1 · Cited by 117 · see citing works
Zhang, S., Che, D., Yang, F., Chi, C., Meng, H., Shen, J., Li, Q., Liu, F., Lv, L., Li, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21068 · Cited by 116 · see citing works
Hotchkiss, K. A., Ashton, A. W., Klein, R. S., Lenzi, M. L., Zhu, G. H., & Schwartz, E. L. (2003) · PubMed · Cited by 115 · see citing works
Zhang, C., Yu, X., Gao, L., Zhao, Y., Lai, J., Lu, D., Bao, R., Jia, B., Zhong, L., Wang, F., et al. (2017) · Theranostics · doi:10.7150/thno.20999 · Cited by 113 · see citing works
Sumitomo, R., Hirai, T., Fujita, M., Murakami, H., Otake, Y., & Huang, C. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.08.023 · Cited by 101 · see citing works
Nakamura, E. S., Koizumi, K., Kobayashi, M., Saitoh, Y., Arita, Y., Nakayama, T., Sakurai, H., Yoshie, O., & Saiki, I. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9006-1 · Cited by 99 · see citing works
Wang, B., Shi, L., Sun, X., Wang, L., Wang, X., & Chen, C. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12781 · Cited by 97 · see citing works
Identification of α‐Mangostin as an Agonist of Human STING
Zhang, Y., Sun, Z., Pei, J., Luo, Q., Zeng, X. Y., Li, Q., Yang, Z., & Quan, J. (2018) · ChemMedChem · doi:10.1002/cmdc.201800481 · Cited by 92 · see citing works
Shiri, S., Alizadeh, A. M., Baradaran, B., Farhanghi, B., Shanehbandi, D., Khodayari, S., Khodayari, H., & Tavasoli, A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3917 · Cited by 92 · see citing works
Lee, H. J., Park, M. K., Lee, E. J., & Lee, C. H. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.018 · Cited by 86 · see citing works
Han, S., Wang, W., Wang, S., Wang, S., Ju, R.-J., Pan, Z., Yang, T., Zhang, G., Wang, H., & Wang, L. (2019) · Nanoscale · doi:10.1039/c9nr03353j · Cited by 82 · see citing works
Che, D., Bo, P., Qiang, T., Shang, L., Liu, F., Shi, J. F., Jingyan, C., Yu, Y., Guangbin, W., & Zhenjun, Y. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.03.004 · Cited by 78 · see citing works
Hirayama, S., Ishii, G., Nagai, K., Ono, S., Kojima, M., Yamauchi, C., Aokage, K., Hishida, T., Yoshida, J., Suzuki, K., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745968 · Cited by 78 · see citing works
Brandão, R. D., Veeck, J., de Vijver, K. K. V., Lindsey, P. J., de Vries, B., van Elssen, C. H. M. J., Blok, M. J., Keymeulen, K., Ayoubi, T., Smeets, H. J. M., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3409 · Cited by 75 · see citing works
Cao, H., Huang, Y., Wang, L., Wang, H., Pang, X., Li, K., Dang, W., Tang, H., Wei, L., Su, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11761 · Cited by 70 · see citing works
Kim, Y. H., Kwon, H., & Kim, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357863 · Cited by 68 · see citing works
Wang, X., Yang, X., Tsai, Y., Li, Y., Chuang, K., Keng, P. C., Lee, S. O., & Chen, Y. (2017) · Radiation Research · doi:10.1667/rr14503.1 · Cited by 65 · see citing works
Zhou, Z., Peng, Y., Wu, X., Meng, S., Yu, W., Zhao, J., Zhang, H., Wang, J., & Li, W. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0410-8 · Cited by 60 · see citing works
Shi, L., Zhang, B., Sun, X., Zhang, X., Lv, S., Li, H., Wang, X., Zhao, C., Zhang, H., Xie, X., et al. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22450 · Cited by 60 · see citing works
Tataroğlu, C., Kargı, A., Özkal, Ş., Eşrefoğlu, N., & Akkoçlu, A. (2003) · Lung Cancer · doi:10.1016/j.lungcan.2003.08.013 · Cited by 59 · see citing works
ExperimentalPneumocystislung infection promotes M2a alveolar macrophage-derived MMP12 production
Nelson, M. P., Christmann, B. S., Dunaway, C. W., Morris, A. M., & Steele, C. H. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00158.2012 · Cited by 56 · see citing works
Cytotoxicity of different sized TiO 2 nanoparticles in mouse macrophages
Zhang, J., Song, W., Guo, J., Zhang, J., Sun, Z., Li, L., Ding, F. H., & Gao, M. (2012) · Toxicology and Industrial Health · doi:10.1177/0748233712442708 · Cited by 54 · see citing works
Pei, B., Sun, B., Zhang, Z.-F., Wang, A., & Ren, P. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.003 · Cited by 45 · see citing works
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer
Nakanishi, T., Imaizumi, K., Hasegawa, Y., Kawabe, T., Hashimoto, N., Okamoto, M., & Shimokata, K. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0133-y · Cited by 43 · see citing works
Cardoso, A. P., Pinto, M. L., Pinto, A. T., Pinto, M. T., Monteiro, C. F., Oliveira, M. I., Santos, S. G., Relvas, J. B., Seruca, R., Mantovani, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1466-8 · Cited by 35 · see citing works
Suppressor Alveolar Macrophages in Mice Bearing Metastatic Lewis Lung Carcinoma Tumors
Young, M. R., Endicott, R. A., Duffie, G. P., & Wepsic, H. T. (1987) · Journal of Leukocyte Biology · doi:10.1002/jlb.42.6.682 · Cited by 31 · see citing works
Metastasis risk after anti-macrophage therapy
Keklikoglou, I., & Palma, M. D. (2014) · Nature · doi:10.1038/nature13931 · Cited by 28 · see citing works
Human Alveolar Macrophages Are Deficient in PTEN
Flaherty, D. M., Monick, M. M., & Hinde, S. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508997200 · Cited by 28 · see citing works
Kimura, Y., Sumiyoshi, M., & Baba, K. (2016) · PubMed · Cited by 25 · see citing works
Russell, N. S., Floot, B., van Werkhoven, E. D., Schriemer, M., de Jong-Korlaar, R., Woerdeman, L. A. E., Stewart, F. A., & Scharpfenecker, M. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.08.024 · Cited by 23 · see citing works
de Cortie, K., Russell, N. S., Coppes, R. P., Stewart, F. A., & Scharpfenecker, M. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.920967 · Cited by 17 · see citing works
ZHU, B., Zou, L., CHENG, X., Lin, Z., DUAN, Y., Wu, Y., ZHOU, F., & Chen, Z. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.09.010 · Cited by 11 · see citing works
Opinion: alternative views of AMP-activated protein kinase
Brenman, J. E., & Temple, B. R. S. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0005-x · Cited by 5 · see citing works
Flagged first, then by citations
4 of the 98 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Macrophage Polarization States in the Tumor Microenvironment
Boutilier, A. J., & Elsawa, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136995 · Cited by 1,631 · see citing works
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 515 · see citing works
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
Wang, H.-G., Yung, M., Ngan, H., Chan, K. K. L., & Chan, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126560 · Cited by 232 · see citing works
Tumor-associated macrophage polarization in the inflammatory tumor microenvironment
Zou, Z., Lin, H., Li, M., & Lin, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1103149 · Cited by 100 · see citing works
NF-κB: Governing Macrophages in Cancer
Cornice, J., Verzella, D., Arboretto, P., Vecchiotti, D., Capece, D., Zazzeroni, F., & Franzoso, G. (2024) · Genes · doi:10.3390/genes15020197 · Cited by 104 · see citing works
Tong, N., He, Z., Ma, Y., Wang, Z., Huang, Z., Cao, H., Xu, L., Zou, Y., Wang, W., Yi, C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.706286 · Cited by 85 · see citing works
Macrophage Polarization: An Important Candidate Regulator for Lung Diseases
Deng, L., Jian, Z., Xu, T., Li, F., Deng, H., Zhou, Y., Lai, S., Xu, Z., & Zhu, L. (2023) · Molecules · doi:10.3390/molecules28052379 · Cited by 81 · see citing works
Piao, H., Fu, L., Wang, Y., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02366-6 · Cited by 77 · see citing works
Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products
Lafta, H. A., AbdulHussein, A. H., Al-Shalah, S. A. J., Alnassar, Y. S., Mohammed, N. M., Akram, S. M., Qasim, M. T., & Najafi, M. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230201145909 · Cited by 61 · see citing works
The abscopal effect: a sense of DNA damage is in the air
Lippert, T. P., & Greenberg, R. A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148274 · Cited by 50 · see citing works
T lymphocyte cell: A pivotal player in lung cancer
Wu, Y., Yuan, M., Wang, C., Chen, Y., Zhang, Y., & Zhang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102778 · Cited by 45 · see citing works
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
Cersosimo, F., Barbarino, M., Lonardi, S., Vermi, W., Giordano, A., Bellan, C., & Giurisato, E. (2021) · Cancers · doi:10.3390/cancers13225664 · Cited by 41 · see citing works
Aldawsari, M. F., Alalaiwe, A. S., Khafagy, E., Saqr, A. A., Alshahrani, S. M., Alsulays, B. B., Alshehri, S., Lila, A. S. A., Rizvi, S. M. D., & Hegazy, W. A. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136833 · Cited by 39 · see citing works
Lim, J. U., Lee, E., Lee, S., Cho, H. J., Ahn, D. H., Hwang, Y., Choi, J. Y., Yeo, C. D., Park, C. K., & Kim, S. J. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-633 · Cited by 36 · see citing works
Günalp, S., Helvaci, D. G., Oner, A., Bursalı, A., Conforte, A. J., Güner, H., Karakülah, G., Szegezdi, É., & Sağ, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1209249 · Cited by 37 · see citing works
Wang, B., Wang, X., Li, P., Niu, X., Liang, X., Liu, G., Liu, Z., & Ge, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.881022 · Cited by 36 · see citing works
Wu, Z. K., Bai, X., Lu, Z., Liu, S., & Jiang, H. (2022) · Journal of Immunology Research · doi:10.1155/2022/6450721 · Cited by 36 · see citing works
Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 34 · see citing works
“The activation of the CCL2/CCR2 axis, which mediates the crosstalk between tumor-associated macrophages (TAMs) and tumor cells, is associated with angiogenesis, metastases, immunosuppression, and cancer progression [27,28].”
BackgroundKariagina, A., & Doseff, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415753 · Cited by 34 · see citing works
Li, Z., Duan, D., Li, L., Peng, D., Ming, Y., Ni, R., & Liu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1382256 · Cited by 31 · see citing works
Malik, S., Sureka, N., Ahuja, S., Aden, D., Zaheer, S., & Zaheer, S. (2024) · Cell Biology International · doi:10.1002/cbin.12226 · Cited by 30 · see citing works
Zhao, B., Hui, X., Zeng, H., Yin, Y., Huang, J., Tang, Q., Ge, G., & Lei, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.634851 · Cited by 30 · see citing works
Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment
Jang, H., Kim, E. H., Chi, S.-G., Kim, S. H., & Yang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810009 · Cited by 31 · see citing works
Hassani, H., Avazzadeh, Z., Agarwal, P., Mehrabi, S., Ebadi, M. J., Dahaghin, M. S., & Naraghirad, E. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-02006-3 · Cited by 29 · see citing works
Ge, W., & Wu, W. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.106.07 · Cited by 27 · see citing works
Yao, P., Su, L., Liu, Z., & Xu, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343316 · Cited by 25 · see citing works
Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β
Hirayama, A., Tanaka, K., Tsutsumi, H., Nakanishi, T., Yamashita, S., Mizusaki, S., Ishii, Y., Ota, K., Yoneshima, Y., Iwama, E., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192861 · Cited by 24 · see citing works
Alveolar macrophages in lung cancer: opportunities and challenges
Chang, C.-Y., Armstrong, D., Corry, D. B., & Kheradmand, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1268939 · Cited by 21 · see citing works
Nowosielska, E. M., Cheda, A., Pocięgiel, M., Cheda, Ł., Szymański, P., & Więdłocha, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126309 · Cited by 20 · see citing works
Yu, T., Han, N., Li, L., Peng, X., Li, Q., Xu, H., Wang, X., Yang, Z., Chen, X., Wang, M.-F., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837784 · Cited by 21 · see citing works
Mestiri, S., Sami, A., Sah, N., El-Ella, D. M. A., Khatoon, S., Shafique, K., Raza, A., Mathkor, D. M., & Haque, S. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10244-8 · Cited by 19 · see citing works
Comparison of lung cancer occurring in fibrotic versus non-fibrotic lung on chest CT
Salvatore, M. M., Liu, Y., Peng, B., Hsu, H. Y., Saqi, A., Tsai, W., Leu, C., & Jambawalikar, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04645-y · Cited by 16 · see citing works
Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner
Trappetti, V., Fazzari, J., Fernández-Palomo, C., Smyth, L. M. L., Potez, M., Shintani, N., Dietler, B. D. B., Martin, O. A., & Djonov, V. (2022) · Biomedicines · doi:10.3390/biomedicines10040735 · Cited by 15 · see citing works
Key role of exosomes derived from M2 macrophages in maintaining cancer cell stemness (Review)
Zhang, W., Zhou, R., Liu, X., You, L., Chen, C., Ye, X., Liu, J., & Liang, Y. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5574 · Cited by 14 · see citing works
Tao, Y., Xiao, J., Li, Y., & Zou, A. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s552449 · Cited by 11 · see citing works
Alipoor, S. D., & Komi, D. E. A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1398077 · Cited by 11 · see citing works
Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions
Zhang, S., & Wang, H. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2410462 · Cited by 10 · see citing works
Moerland, J. A., Leal, A. S., Lockwood, B., Demireva, E. Y., Xie, H., Krieger-Burke, T., & Liby, K. T. (2023) · Antioxidants · doi:10.3390/antiox12010116 · Cited by 10 · see citing works
Tsao, C., Wu, H., Wang, Y.-F., Shen, P., Wu, W.-T., Chen, H.-Y., & Dai, Y.-H. (2022) · Biomedicines · doi:10.3390/biomedicines10071539 · Cited by 8 · see citing works
Prognostic utility of TME-associated genes in pancreatic cancer
Nie, Y., Xu, L., Bai, Z., Liu, Y., Wang, S., Zeng, Q., Gao, X., Xia, X., & Chang, D. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1218774 · Cited by 8 · see citing works
Woo, S. J., Kim, Y., Kang, H., Jung, H., Youn, D. H., Hong, Y., Lee, J. J., & Hong, J. Y. (2024) · Respiratory Research · doi:10.1186/s12931-024-02829-8 · Cited by 8 · see citing works
Kawaguchi, Y., Okamoto, K., Kataoka, Y., Shibata, K., Saito, H., Shiratori, T., Ueda, K., Ohshio, Y., & Hanaoka, J. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03800-8 · Cited by 8 · see citing works
The immune microenvironment of lung adenocarcinoma featured with ground‐glass nodules
Zhao, C., Xiao, R., Jin, H., & Li, X. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15380 · Cited by 6 · see citing works
Wang, M., Li, S., Li, R., Ning, F., & Tian, L. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01260-x · Cited by 7 · see citing works
Xie, F., Li, Y., & Liang, B. (2022) · BioMed Research International · doi:10.1155/2022/7798654 · Cited by 7 · see citing works
Kwiecień, I., Rutkowska, E., Raniszewska, A., Rzeszotarska, A., Polubiec-Kownacka, M., Domagala-Kulawik, J. J., Korsak, J., & Rzepecki, P. (2023) · Cancers · doi:10.3390/cancers15215175 · Cited by 7 · see citing works
Darya, G. H., Zare, O., Karbalaei‐Heidari, H. R., Zeinali, S., Sheardown, H. D., & Rastegari, B. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2347300 · Cited by 6 · see citing works
Liu, X., Ye, J., Guo, W., & Wang, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1473044 · Cited by 6 · see citing works
Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets
Suliman, M., Saleh, R. O., Chandra, M., Rasool, K. H., Jabir, M. S., Jawad, S. F., Hasan, T. F., Singh, M., Singh, M., & Singh, A. (2025) · Medical Oncology · doi:10.1007/s12032-025-02643-2 · Cited by 6 · see citing works
Bag, S., Oetjen, J., Shaikh, S., Chaudhary, A., Arun, P., & Mukherjee, G. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04713-3 · Cited by 6 · see citing works
Piao, H., Fu, L., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1186986/v1 · Cited by 5 · see citing works
Khanduri, I., Maki, H., Verma, A., Katkhuda, R., Anandappa, G., Pandurengan, R. K., Zhang, S., Mejia, A., Tong, Z., Soto, L. M. S., et al. (2024) · BJC Reports · doi:10.1038/s44276-024-00056-8 · Cited by 4 · see citing works
Shiba, S., Harao, M., Saito, A., SAKURAGI, M., Kitayama, J., & Sata, N. (2024) · Journal of Breast Cancer · doi:10.4048/jbc.2023.0285 · Cited by 4 · see citing works
Wang, J., Wu, W., Xia, J., Chen, L., Liu, D., Wang, G., Wang, L., & Zheng, Q. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1012 · Cited by 3 · see citing works
Dehkordi, A. S., Sayahinouri, M., Hosseininia, H. S., Kazempour, A., Araghinia, R. M., Partan, A. S., Sadrabadi, A. E., & Jalili, A. (2023) · Iranian Journal of Blood and Cancer · doi:10.61186/ijbc.15.4.236 · Cited by 3 · see citing works
Zhong, S., & Borlak, J. T. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03671-5 · Cited by 3 · see citing works
CARD9 as a potential therapeutic target in lung cancer
Sheng, R., & Yang, Z. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5055 · Cited by 2 · see citing works
Yu, C., Chen, J., Deng, J., Li, H., Zhuang, Q., Luo, B., Ye, H., & Tian, H. (2025) · PeerJ · doi:10.7717/peerj.19920 · Cited by 1 · see citing works
Li, M., Wang, Z., Huang, B., Lai, Y., Zhang, M., & Lin, C. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1519677 · Cited by 1 · see citing works
Wang, Z., Shen, Y., & Xu, Q. (2021) · Research Square · doi:10.21203/rs.3.rs-938022/v1 · Cited by 1 · see citing works
Stepanov, Y. V., Yakshibaeva, Y., & Kolesnik, D. L. (2023) · InterConf · doi:10.51582/interconf.19-20.10.2023.018
Piao, H., Fu, L., Wang, Y., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19766367
Piao, H., Fu, L., Wang, Y., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19766364
Bushara, O., D’Orleans, C. C., Kadakia, Y. H., Alur, R., Devaro, D., & Singhal, S. K. (2025) · Pathobiology · doi:10.1159/000546745
Shchelokova, E. E., Коган, Е. А., Avraamova, S. T., Демура, Т. А., Zharkov, N. V., Kovyazina, N. V., Mordovina, A. I., Zelenchenkova, P. I., Meerovich, G. A., & Reshetov, I. V. (2025) · Russian Journal of Archive of Pathology · doi:10.17116/patol20258705165
Piao, H., Fu, L., Wang, Y., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19766361
Piao, H., Fu, L., Wang, Y., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19766370
Aseeri, A. A., AlKhafaje, Z., Hussein, U. A.-R., Adel, Z., Alkadir, O. K. A., Aldulaimi, A., Saeed, S. M., Taher, W. M., Alwan, M., & Smerat, A. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10504-2
- Authors
- Xu, F., Wei, Y., Tang, Z., Liu, B., & Dong, J.
- Affiliations
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
- Fudan University (CN)
- Corresponding author
- Liu, Baojun
- Dong, Jingcheng
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2020-09-17
- Volume
- 22
- Issue
- 5
- Pages
- 4107-4115
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- PMC
- PMC7533506
- OpenAlex
- W3087366847
- Cited by
- 67
- References
- 98
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 17 · 2023: 20 · 2022: 11 · 2021: 11
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Molecular Medicine Reports (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, lung cancer, tumor microenvironment, M2 macrophage polarization, M1 macrophage polarization, tumor-infiltrating immune cells, metastasis, angiogenesis, anti-tumor therapy, TAM-targeted therapy
- MeSH terms
- Tumor-Associated Macrophages, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Cell Polarity, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review